Latest Articles
- How should hyperuricemia be treated in a patient with allopurinol hypersensitivity?
If other methods of lowering uric acid fail, desensitization to allopurinol is an option but poses serious risks.
- New cholesterol guidelines: Better, but harder to follow
The new guidelines on lowering cholesterol are good in theory but may prove cumbersome in practice.
- Using the new cholesterol guidelines in everyday practice
Many more patients have become candidates for lipid-lowering therapy under new guidelines recently released.
- Recognizing and treating social anxiety disorder
Consider this diagnosis when a patient avoids social situations because of marked and persistent fear and anxiety.
- Does salmeterol increase mortality in patients with COPD?
Salmeterol is safe and FDA-approved, but it should be used only as part of a total program that includes education, smoking cessation, oxygen supplementation, and rehabilitation.
- Mitochondrial cytopathy in adults: What we know so far
The manifestations of mitochondrial cycopathy are remarkably diverse, and the syndromes identified so far probably represent only a few of the disorders.
- Use of cholinesterase inhibitors for treatment of Alzheimer disease
These drugs may slow but do not halt disease progression. They may be most beneficial if started early.
- Maximizing response to erythropoietin in treating HIV-associated anemia
A number of treatable factors can impair the response to erythropoietin in HIV patients.